The world’s big pharmaceutical companies are cutting back their research into treatment for Alzheimer’s, after being hit by the failure of a number of high profile, and expensive, drugs trials. Sir John Bell, Life Sciences Champion for the government, and Stephen Whitehead, head of the Association of the British Pharmaceutical Industry discuss why it is proving so hard to find something that works.

BBC Radio4 Today: Thursday 20th September 07:50 BST